Indivior to Participate in Investor Conferences

RNS Number : 0573R

Indivior PLC

02 November 2021

 

Indivior to Participate in Upcoming Healthcare Investor Conferences

Richmond, VA, November 2, 2021 - Indivior PLC (LON: INDV) will participate in the upcoming healthcare investor conferences:

· STIFEL 2021 Virtual Healthcare Conference

Day :   Monday, November 15^th:

Time :   8:40 AM US Eastern (13:40 London time)

Speaker :   Mark Crossley, CEO

Link :   Click here

· Jefferies 2021 London Healthcare Conference

Day:   Tuesday, November 16^th

Time:   8:00 AM London Time (3:00 AM US Eastern)

Speaker:   Mark Crossley, CEO

Link:   Click here

About Indivior

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat addiction and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and cooccurring disorders of addiction, including alcohol use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 800 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior .

Investor Contact:

Jason Thompson, Investor Relations

Mobile:  [phone]

E-mail:   [e-mail]

-ends-

 

END

 

 

MSCEANFAEDFFFEA